Last update 08 May 2025

TfR1 x NAGLU

Basic Info

Related Targets
TfR1NAGLU

Related

1
Drugs associated with TfR1 x NAGLU
JR-446
Target
NAGLU x TfR1
Mechanism
NAGLU agonists [+1]
Active Org.
JCR Pharmaceuticals Co., Ltd.JCR Pharmaceuticals Co., Ltd.
Originator Org.
JCR Pharmaceuticals Co., Ltd.JCR Pharmaceuticals Co., Ltd.
Active Indication
Mucopolysaccharidosis III
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with TfR1 x NAGLU
NCT06488924
/ RecruitingPhase 1/2
An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
100 Clinical Results associated with TfR1 x NAGLU
Login to view more data
100 Translational Medicine associated with TfR1 x NAGLU
Login to view more data
0 Patents (Medical) associated with TfR1 x NAGLU
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free